Literature DB >> 8621414

Phosphorylation of aquaporin-2 does not alter the membrane water permeability of rat papillary water channel-containing vesicles.

M B Lande1, I Jo, M L Zeidel, M Somers, H W Harris.   

Abstract

Antidiuretic hormone modulates the water permeability (Pf) of epithelial cells in the rat kidney by vesicle-mediated insertion and removal of the aquaporin-2 (AQP-2) water channel. AQP-2 possesses a single consensus cAMP-dependent protein kinase A (PKA) phosphorylation site (Ser-256) hypothesized to regulate channel Pf(Kuwahara, M., Fushimi, K., Terada, Y., Bai, L., Sasaki, S., and Marumo, F. (1995) J. Biol. Chem. 270, 10384-10387). To test whether PKA phosphorylation of AQP-2 alters channel Pf, we compared the Pf values of purified AQP-2 endosomes after incubation with either PKA or alkaline phosphatase. Studies using [gamma-32P]ATP reveal that AQP-2 endosomes contain endogenous PKA and phosphatase activities that add and remove 32P label from AQP-2. However, the Pf (0.16 +/- 0.06 cm/s) of endosomes containing phosphorylated AQP-2 (0.7 +/- 0. 3 mol of PO4/mol of protein) is not significantly different from the same AQP-2 endosomes where 95 +/- 8% of the phosphate has been removed (Pf 0.14 +/- 0.06 cm/s). These data do not support a role for PKA phosphorylation in alteration of AQP-2's Pf. Instead, AQP-2 phosphorylation by PKA may modulate AQP-2's distribution between plasma membrane and intracellular vesicle compartments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621414     DOI: 10.1074/jbc.271.10.5552

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Phosphorylation of aquaporin-2 regulates its water permeability.

Authors:  Kayoko Eto; Yumi Noda; Saburo Horikawa; Shinichi Uchida; Sei Sasaki
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

Review 2.  Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders.

Authors:  Yumi Noda
Journal:  Clin Exp Nephrol       Date:  2013-10-16       Impact factor: 2.801

3.  Expression of a dominant negative PKA mutation in the kidney elicits a diabetes insipidus phenotype.

Authors:  Merle L Gilbert; Linghai Yang; Thomas Su; G Stanley McKnight
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

4.  Water transport activity of the plasma membrane aquaporin PM28A is regulated by phosphorylation.

Authors:  I Johansson; M Karlsson; V K Shukla; M J Chrispeels; C Larsson; P Kjellbom
Journal:  Plant Cell       Date:  1998-03       Impact factor: 11.277

5.  Role of multiple phosphorylation sites in the COOH-terminal tail of aquaporin-2 for water transport: evidence against channel gating.

Authors:  Hanne B Moeller; Nanna MacAulay; Mark A Knepper; Robert A Fenton
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

Review 6.  Cell biology of vasopressin-regulated aquaporin-2 trafficking.

Authors:  Hanne B Moeller; Robert A Fenton
Journal:  Pflugers Arch       Date:  2012-06-29       Impact factor: 3.657

7.  Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2.

Authors:  Jason D Hoffert; Robert A Fenton; Hanne B Moeller; Brigitte Simons; Dmitry Tchapyjnikov; Bradley W McDill; Ming-Jiun Yu; Trairak Pisitkun; Feng Chen; Mark A Knepper
Journal:  J Biol Chem       Date:  2008-07-07       Impact factor: 5.157

Review 8.  Water homeostasis: evolutionary medicine.

Authors:  Mark L Zeidel
Journal:  Trans Am Clin Climatol Assoc       Date:  2012

9.  The subcellular localization of an aquaporin-2 tetramer depends on the stoichiometry of phosphorylated and nonphosphorylated monomers.

Authors:  E J Kamsteeg; I Heijnen; C H van Os; P M Deen
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

Review 10.  The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases.

Authors:  Tanja Vukićević; Maike Schulz; Dörte Faust; Enno Klussmann
Journal:  Front Pharmacol       Date:  2016-02-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.